XCMR Awarded Patent for Protective Respirator Utilizing Far UV-C Irradiation

PHILADELPHIA, PA—October 24, 2023: XCMR Inc., a medtech company that develops proprietary UV-C technology to prevent the transmission of infectious diseases, announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,793,904 for its groundbreaking protective respirator technology.

XCMR Team Presents Groundbreaking Research at IUVA 2023 World Congress

The 2023 International Ultraviolet Association (IUVA) World Congress, held in Dubai, UAE, from September 10–13, convened global leaders in UV technology. This premier event featured the latest research, innovations, and applications of ultraviolet (UV) technology in sectors such as public health, water treatment, and environmental protection.

XCMR Presents at the First International Congress on Far-UVC Science and Technology (ICFUST)

XCMR’s team presented groundbreaking research at the inaugural ICFUST conference, which convened more than 200 attendees to discuss advancements in Far UV-C technology. The event focused on the latest applications of Far UV-C for public health, pathogen inactivation, and environmental protection.

XCMR CEO Richard Rasansky Contributes to 2023 Convergent Research Roadmapping Workshop

Light in the 200-235 nm range, or Far UV-C, is one of the most promising tools for dramatically reducing airborne transmission from day one of almost any pandemic caused by airborne pathogens. If adopted widely, it could also have a dramatic impact on seasonal flu, colds, and endemic COVID-19.

XCMR Presents Breakthrough Research at ICULTA 2023

Dr. Karl G. Linden presented innovative research on UV LED technology at the International Conference on UV LED Technologies & Applications (ICULTA 2023), showcasing advancements in personal protective equipment (PPE) for biodefense.

XCMR Welcomes Christopher Bowers as Computational Analyst

XCMR is pleased to announce that Dr. Christopher Bowers has joined our team as a computational analyst in the Modeling and Simulations group. Dr. Bowers brings a wealth of experience in computational fluid dynamics and a passion for leveraging advanced modeling techniques to drive innovation.

XCMR Welcomes Eric Prast as VP of Product Engineering

XCMR is pleased to announce the appointment of Eric Prast as our new vice-president of product engineering. Mr. Prast brings over ten years of product development experience across various sectors, including biomedical, analytical instruments, and global industrial equipment manufacturing.

XCMR Secures $399,999 subcontract for Far UV-C Technology Development with Eden Park Illumination

Building on the success of its earlier partnership with Eden Park, XCMR has inked a second subcontract for $399,999. This funding will further the development of personal protective respirators that employ human-safe, miniature Far UV-C microplasma lamps.

XCMR Secures $784,502 AFWERX Phase 2 Award to Advance Next-Generation PPE Development

Following the success of its Phase 1 project, XCMR has been awarded a $784,502 Phase 2 AFWERX award by the Department of Defense. This funding will further support the development of XCMR’s next-generation personal protective equipment (PPE) for real-time inactivation of airborne biological threats.

EPA Announces Over $3 Million in Funding to Small Businesses to Develop Environmental Technologies

“With technology constantly changing, we need innovation and cutting-edge technology to keep up with the demands that we find ourselves thrust in from the pandemic,” EPA Mid-Atlantic Regional Administrator Adam Ortiz. “XCMR is helping in this fight with their skills and know-how, which complements our mission of protecting human health and the environment.”

News